A Case of Drug-Induced Liver Injury Secondary to Natalizumab
A 33-year-old Caucasian female with relapsing-remitting multiple sclerosis presented with abdominal pain, nausea, and vomiting and was found to have acute liver injury. After thorough investigation, she was diagnosed with drug-induced liver injury (DILI) thought secondary to redosing of Natalizumab...
Saved in:
| Main Authors: | Phillip P. Santoiemma, Haripriya Maddur, Christopher M. Moore |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Case Reports in Hepatology |
| Online Access: | http://dx.doi.org/10.1155/2020/7976585 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Case of Drug-Induced Liver Injury Secondary to Ceftriaxone
by: Rupesh Ramtel
Published: (2025-06-01) -
Recrudescence of Natalizumab‐Induced Pneumonitis and Peripheral Hypereosinophilia: Case Report and Literature Review
by: Gerardo Arwi, et al.
Published: (2025-04-01) -
Natalizumab treatment for multiple sclerosis
by: Maria Lucia Brito Ferreira
Published: (2014-12-01) -
Impact of natalizumab on ambulatory improvement in secondary progressive and disabled relapsing-remitting multiple sclerosis.
by: Diego Cadavid, et al.
Published: (2013-01-01) -
Natalizumab-associated progressive multifocal leukoencephalopathy
by: Trevor Glenn, et al.
Published: (2025-06-01)